A Primary Mediastinal Large B-Cell Lymphoma Patient With COVID-19 Infection After Intensive Immunochemotherapy: A Case Report

A Primary Mediastinal Large B-Cell Lymphoma Patient With COVID-19 Infection After Intensive Immunochemotherapy: A Case Report

Background: The outbreak of coronavirus disease 2019 (COVID-19) had become a global public health event. Lymphoma patients need to be distinguished from the general population because of their deficient immune status and intensive anti-tumor treatment. The impacts of cancer subtypes and treatment on...

Full description

Bibliographic Details
Main Authors: Qiuhui Li, Fang Zhu, Yin Xiao, Tao Liu, Xinxiu Liu, Gang Wu, Liling Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-05-01
Series:Frontiers in Oncology
Subjects:
COVID-19
lymphoma
myelosuppression
chemotherapy
immunotherapy
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00924/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.00924/full

Similar Items